FDA Clears Diagnostic Hybrids Influenza A/Influenza B Identification Kit
Diagnostic Hybrids announces FDA 510k clearance of its D3 FastPoint L-DFA Influenza A/ Influenza B Virus Identification Kit, which allows for the identification of influenza A virus and influenza B virus from a patients specimen in under 30 minutes.
Read More